コロラド州における悪性黒色腫の臨床試験
コロラド州内の拠点で、悪性黒色腫に関する32件の研究が参加者を募集しています。
コロラド州内の都市
- Denver19件の研究
- Aurora18件の研究
- Highlands Ranch5件の研究
- Colorado Springs4件の研究
- Boulder3件の研究
- Centennial3件の研究
- Westminster3件の研究
- Lakewood3件の研究
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- 他15件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Phase 1 Study of PF-08046033 in Advanced Solid Tumors
- Presbyterian/St Lukes Medical Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07519655BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- UCHealth Memorial Hospital Central, Colorado Springs
- Memorial Hospital North, Colorado Springs
- Poudre Valley Hospital, Fort Collins
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Rocky Mountain Regional VA Medical Center, Aurora
- University of Colorado Cancer Center, Aurora
- The Melanoma And Skin Cancer Institute, Englewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- University of Colorado Cancer Center, Aurora
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904Pan-tumor MRD Study
- The Melanoma and Skin Cancer Institute, Englewood
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- UCHealth University of Colorado Hospital, Aurora
- Penrose-Saint Francis Healthcare, Colorado Springs
- Rocky Mountain Cancer Centers-Penrose, Colorado Springs
- 他7件
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
- Sarah Cannon Research Institute, Denver
被験者募集中第1相
18歳〜80歳 · 全性別 · 2026/09/18更新 · NCT06398418A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0182, Aurora
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Rocky Mountain Cancer Centers-Aurora, Aurora
- University of Colorado Hospital, Aurora
- Boulder Community Foothills Hospital, Boulder
- 他15件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Colorado, Aurora
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Skin Cancer Institute, Englewood
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07287917A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
- Sarah Cannon Research Institute Denver, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT04913285Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Project: Every Child for Younger Patients With Cancer
- Children's Hospital Colorado, Aurora
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
- University of Colorado Hospital, Aurora
被験者募集中
55歳以上 · 全性別 · 2026/08/07更新 · NCT07704918A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Call for Information (Investigational Site 0019), Aurora
被験者募集中第1/2相
6 Months – 17 Years · 全性別 · 2026/07/06更新 · NCT02332668Integrated Cancer Repository for Cancer Research
- Advent Health, Greenwood Village
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- SCRI Oncology Partners- Denver, Denver
被験者募集中第1/2相
18歳〜70歳 · 全性別 · 2026/06/15更新 · NCT06940739Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- SCRI - Denver, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/08更新 · NCT03947385DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA01-0, Wheat Ridge
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Colorado, Anschutz Medical Campus, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/13更新 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- University of Colorado Hospital, Aurora
- The Melanoma and Skin Cancer Institute, Englewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/06更新 · NCT07015190A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
- University of Colorado Anschutz, Aurora
- University of Colorado, Denver
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/04/22更新 · NCT06624644A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
- Sarah Cannon Research Institute at Health ONE, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/20更新 · NCT06326411A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- University of Colorado Cancer Center, Aurora
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06362369A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University of Colorado Hospital - Anschutz Cancer Pavilion(ACP), Aurora
- The Melanoma & Skin Cancer Institute, Englewood
被験者募集中第2/3相
全年齢 · 全性別 · 2026/04/02更新 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Rocky Mountain Cancer Centers-Aurora, Aurora
- Rocky Mountain Cancer Centers-Boulder, Boulder
- Rocky Mountain Cancer Centers - Centennial, Centennial
- 他12件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/02/13更新 · NCT05669430Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- Sarah Cannon Research Institute at HealthONE, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2024/11/15更新 · NCT04787042ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。